This video will also appear as a podcast on Monday.

$AMD (-0.36%)

$PLTR (-1.22%)

$BTC (+0.09%)

https://www.youtube.com/watch?v=YXMiGQFXv0k&

Of course $TSLA (-1%) massively overvalued! Does that make it a clear short position? Absolutely not! $TSLA (-1%) is not a normal commercial enterprise. $TSLA (-1%) is a religion, just like $AAPL (-0.72%) .

Every piece of bad news is bought, every hot air statement by the CEO, no matter how unrealistic, is bought. $TSLA (-1%) is for me one of the easiest stocks to manipulate with such a market volume.

No matter what is said, the disciples buy, buy and buy. So no, $TSLA (-1%) is like $PLTR (-1.22%) a stock that is extremely risky to trade against.

Let's take robotaxis as an example. The share price jumps because, after many promises, 10 cars have been put on the road as assisted driving with a passenger and an accompanying vehicle. But only in good weather and in bright light.

The profits to be generated from this are extrapolated as if there were no competition and it will be rolled out across the board from 2027. Just for comparison, it took Waymo 7 years to get permission to drive the vehicles without an attendant. Even if there is a very risk-averse government in the USA right now, but I believe that this will still be decided by the states and not by decree. That's why it started in Texas. It will take at least 10 years to roll it out across the whole of the USA. In Europe, I don't think it will be before 2050.

There is plenty of competition, just like with humanoid robots. The cars will only be bought by the religious community.

I think it will stay that way.

And even though I'm assuming a highly exaggerated valuation, I'm not going to bet against this religion.

I think the fair value is between 100-150 rather than 400-500, but I don't believe it will get that far.

Enclosed is the chart from $PLTR (-1.22%) I see more of a sell here, both fundamentally and in terms of the chart, so I took a quick look at the chart.

At Palantir ($PLTR) (-1.22%) there has been such a dilution for years, as there are huge stock-based compensations, this dilutes the company so much that the growth looks more minimal.

Take a look for yourself:

Reported operating cash flow: USD 1,335 million

- less share-based compensation (SBC): 722 million dollars

- less interest income: 204 million dollars

= Actual operating cash flow: 409 million US dollars

In addition, 2019 revenue increased by ~300% but only by 50% per share

2019 (TTM at the end of the year): approx. 0,80 $ per share

2024 (for the full year): approx. 1,17 $ per share

I find the PS ratio of 114 at $PLTR (-1.22%) frighteningly high! When have we seen something like this on the stock market that is then relativized by growth?

Of course the company is growing strongly and now it could also participate more in the 5% NATO spending, but how fast?

Opportunity costs are too high: there are better stocks on the market!

Regencell Bioscience shoots up by 64,000%

Regencell Bioscience Holdings Limited, a biotech company specializing in traditional herbal medicine, has undergone a breathtaking development this year. With an increase of over 46,000%, the company, which was still considered a penny stock in April 2024, has now reached a market value of almost 30 billion dollars. In the previous year, its market capitalization was still a modest 53 million dollars. However, things are not looking rosy financially: In the financial year ending June 2024, Regencell reported a net loss of 4.4 million dollars, a decrease of 28% compared to the previous year. Recently, the board decided to conduct a 38-for-1 stock split, which led to a 283% jump in the share price. This is the biggest daily gain in almost a year. Regencell, which debuted on the Nasdaq Capital Market in 2021, is currently in the research and development phase and has not generated any revenue since its inception. The company is pursuing the ambitious goal of treating neurological disorders such as ADHD and autism with traditional herbal medicine. Despite a promising trial for Covid-19, Regencell's future remains uncertain.

Palantir reaches all-time high

In the USA, Palantir Technologies $PLTR (-1.22%) reached an impressive all-time high on Monday, closing at 141.41 dollars - an increase of around 3% compared to Friday. This positive performance came at a time when US indices were coming back from previous losses, while investors were closely watching the tense developments in the conflict between Israel and Iran. Loop Capital last week called Palantir shares a "train that never comes back" and raised its price target to $155, well above the consensus of $95. Palantir shares are already up nearly 90% this year, attributed in part to the company's growing role with the U.S. government. Palantir's Foundry software platform is now used in several government agencies, including the Department of Homeland Security, showing how important the company has become in the current geopolitical landscape.

Sources:

https://finance.yahoo.com/news/herbal-medicine-stock-no-sales-173944789.html

https://finance.yahoo.com/news/palantir-stock-sets-time-high-204217705.html

Hello everyone,

I've been thinking about how to invest my first €10,000. I would like to pursue the core satellite strategy.

What do you think of the following allocation?

• $VWRL (-1.12%) (approx. 20%)
• $TDIV (-0.87%) (approx. 15%)
• $BTC (+0.09%) (I already have a part, the rest I will buy -- 10%)
• Cash (5%)

The other 50% will go into the first 10 shares.

• $PLTR (-1.22%) (4x)
• $CAT (+0.07%) (2x)
• $HOOD (-1.05%) (7x)
• $MCD (-0.37%) (2x)
• $AMZN (-0.78%) (2x)
• $NOVO B (+2.21%) (6x)
• $KO (+0.48%) (7x)
• $STR (-2.51%) (is my employer, have been invested for approx. 5 years -- 6x)
• $AAPL (-0.72%) (3x)
• $SHOP (-1.03%) (5x)

I would like to end up with a total of about 15 shares.

In the next three places would be the following shares:

• $NU (-1.04%)
• 
  $HIMS (-0.44%)
• 
  $SOFI (-0.38%)

I look forward to hearing your opinions and wish everyone a successful week.

Best regards

Sherlock✌🏻

$PLTR (-1.22%)